Display options
Share it on

Nanomedicine. 2011 Apr;7(2):123-30. doi: 10.1016/j.nano.2010.09.004. Epub 2010 Sep 29.

Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells.

Nanomedicine : nanotechnology, biology, and medicine

Kenneth T Thurn, Hans Arora, Tatjana Paunesku, Aiguo Wu, Eric M B Brown, Caroline Doty, Jeff Kremer, Gayle Woloschak

Affiliations

  1. Department of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

PMID: 20887814 PMCID: PMC3062699 DOI: 10.1016/j.nano.2010.09.004

Abstract

UNLABELLED: Nanotechnology has introduced many exciting new tools for the treatment of human diseases. One of the obstacles in its application to that end is the lack of a fundamental understanding of the interaction that occurs between nanoparticles and living cells. This report describes the quantitative analysis of the kinetics and endocytic pathways involved in the uptake of anatase titanium dioxide (TiO(2)) nanoparticles into prostate cancer PC-3M cells. The experiments were performed with TiO(2) nanoconjugates: 6-nm nanoparticles with surface-conjugated fluorescent Alizarin Red S. Results obtained by flow cytometry, fluorescence microscopy, and inductively coupled plasma-mass spectrometry confirmed a complex nanoparticle-cell interaction involving a variety of endocytic mechanisms. The results demonstrated that a temperature, concentration, and time-dependent internalization of the TiO(2) nanoparticles and nanoconjugates occurred via clathrin-mediated endocytosis, caveolin-mediated endocytosis, and macropinocytosis.

FROM THE CLINICAL EDITOR: The interaction and uptake of TiO(2) nanoparticles (6-nm) with prostate PC-3M cells was investigated and found to undergo temperature, time, and concentration dependent intracellular transport that was mediated through clathrin pits, caveolae, and macropinocytosis. These results suggest that nanoparticles may widely permeate through tissues and enter almost any active cell through a variety of biological mechanisms, posing both interesting opportunity and possible challenges for systemic use.

Copyright © 2011 Elsevier Inc. All rights reserved.

References

  1. J Hazard Mater. 2007 Jul 31;146(3):668-73 - PubMed
  2. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):141-51 - PubMed
  3. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8 - PubMed
  4. J Occup Med. 1992 Feb;34(2):164-9 - PubMed
  5. Biomacromolecules. 2008 Feb;9(2):435-43 - PubMed
  6. Nanoscale Res Lett. 2007 Aug 15;2(9):430-41 - PubMed
  7. Methods Mol Biol. 2008;440:15-33 - PubMed
  8. Cell. 2008 Jan 11;132(1):113-24 - PubMed
  9. Nano. 2008 Feb 1;3(1):27-36 - PubMed
  10. Appl Environ Microbiol. 2005 Jan;71(1):270-5 - PubMed
  11. Cell. 1983 May;33(1):273-85 - PubMed
  12. Trends Cell Biol. 2004 Jul;14(7):352-8 - PubMed
  13. Langmuir. 2007 Jul 3;23(14):7880-5 - PubMed
  14. Small. 2009 Jun;5(11):1318-25 - PubMed
  15. Prog Neurobiol. 2009 Feb;87(3):133-70 - PubMed
  16. Small. 2008 Apr;4(4):485-91 - PubMed
  17. Artif Organs. 2008 Feb;32(2):167-74 - PubMed
  18. J Toxicol Environ Health. 1990;29(4):417-29 - PubMed
  19. J Cell Physiol. 1989 Mar;138(3):519-26 - PubMed
  20. Mol Biol Cell. 2003 Aug;14(8):3254-65 - PubMed
  21. FEMS Microbiol Lett. 2006 May;258(1):18-24 - PubMed
  22. Small. 2009 Mar;5(3):370-6 - PubMed
  23. J Cell Biol. 1993 Apr;121(1):61-72 - PubMed
  24. Clin Lab. 2007;53(7-8):413-21 - PubMed
  25. Exp Cell Res. 1999 Dec 15;253(2):629-36 - PubMed
  26. Biochem Biophys Res Commun. 2007 Feb 2;353(1):26-32 - PubMed
  27. Nat Rev Mol Cell Biol. 2006 Jun;7(6):404-14 - PubMed
  28. Scand J Work Environ Health. 1987 Feb;13(1):47-51 - PubMed
  29. Cancer Cell. 2003 Dec;4(6):499-515 - PubMed
  30. Biomaterials. 2007 Jun;28(18):2876-84 - PubMed
  31. J Cell Biol. 1993 Mar;120(6):1449-59 - PubMed
  32. Traffic. 2002 Jul;3(7):443-51 - PubMed
  33. Nat Mater. 2003 May;2(5):343-6 - PubMed
  34. Biochim Biophys Acta. 2005 Dec 30;1746(3):349-63 - PubMed
  35. Photochem Photobiol. 1996 Jul;64(1):188-93 - PubMed
  36. Nat Rev Cancer. 2008 Nov;8(11):835-50 - PubMed
  37. Biomaterials. 2007 Jul;28(19):2959-66 - PubMed
  38. Clin Exp Metastasis. 1996 Sep;14(4):389-98 - PubMed
  39. World J Gastroenterol. 2004 Nov 1;10(21):3191-3 - PubMed

Substances

MeSH terms

Publication Types

Grant support